These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30570424)

  • 1. Approaches to monitoring intussusception following rotavirus vaccination.
    Tate JE; Parashar UD
    Expert Opin Drug Saf; 2019 Jan; 18(1):21-27. PubMed ID: 30570424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intussusception following rotavirus vaccination: an updated review of the available evidence.
    Rha B; Tate JE; Weintraub E; Haber P; Yen C; Patel M; Cortese MM; DeStefano F; Parashar UD
    Expert Rev Vaccines; 2014 Nov; 13(11):1339-48. PubMed ID: 25066368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Intussusception with Rotavirus Vaccine.
    Kalaiselvan V; Thota P; Kumar V; Rathore MS; Thota A; Singh GN
    Indian J Pediatr; 2017 Feb; 84(2):97-100. PubMed ID: 27641974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol.
    Reddy S; Nair NP; Giri S; Mohan VR; Tate JE; Parashar UD; Gupte MD; Arora R; Kang G;
    BMC Public Health; 2018 Jul; 18(1):898. PubMed ID: 30029630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.
    Zanardi LR; Haber P; Mootrey GT; Niu MT; Wharton M
    Pediatrics; 2001 Jun; 107(6):E97. PubMed ID: 11389295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.
    Yen C; Healy K; Tate JE; Parashar UD; Bines J; Neuzil K; Santosham M; Steele AD
    Hum Vaccin Immunother; 2016 Oct; 12(10):2580-2589. PubMed ID: 27322835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012.
    Haber P; Patel M; Pan Y; Baggs J; Haber M; Museru O; Yue X; Lewis P; Destefano F; Parashar UD
    Pediatrics; 2013 Jun; 131(6):1042-9. PubMed ID: 23669521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccine and intussusception. Where do we go from here?
    Dennehy PH; Bresee JS
    Infect Dis Clin North Am; 2001 Mar; 15(1):189-207, x-xi. PubMed ID: 11301815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between rotavirus vaccination and intussusception: implications for vaccine strategies.
    Cale CM; Klein NJ
    Gut; 2002 Jan; 50(1):11-2. PubMed ID: 11772959
    [No Abstract]   [Full Text] [Related]  

  • 13. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
    Escolano S; Hill C; Tubert-Bitter P
    Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination.
    Niu MT; Erwin DE; Braun MM
    Vaccine; 2001 Sep; 19(32):4627-34. PubMed ID: 11535310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).
    Costantino C; Restivo V; Cuccia M; Furnari R; Amodio E; Vitale F
    Ital J Pediatr; 2015 Aug; 41():52. PubMed ID: 26232152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intussusception and rotavirus vaccines: what is the background risk?
    Sáez-Llorens X; Guevara JN
    Pediatr Infect Dis J; 2004 Apr; 23(4):363-5. PubMed ID: 15071297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception].
    Pérez-Vilar S; Díez-Domingo J; Gomar-Fayos J; Pastor-Villalba E; Sastre-Cantón M; Puig-Barberà J
    An Pediatr (Barc); 2014 Aug; 81(2):77-85. PubMed ID: 24252603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at First Rotavirus Vaccination and Risk of Intussusception in Infants: A Public Health Modeling Analysis.
    Yung CF; Chong CY; Thoon KC
    Drug Saf; 2016 Aug; 39(8):745-8. PubMed ID: 27067440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
    Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.